Vaccine Development Related News
ARM-002TM anti-cancer vaccine shows promise in combatting pre-established melanoma
Defence Therapeutics Inc. has unveiled the exceptional efficacy of its second-generation ARMTM anti-cancer vaccine.
The anti-cancer vaccine, dubbed ARM-002TM, has demonstrated proficiency in combating pre-established...
Discover B Medical Systems’ medical refrigerators, freezers, and transport boxes
B Medical Systems S.a r.l (formely Dometic/Electrolux) is a global manufacturer and distributor of innovative vaccine storage solutions, including vaccine cold chain and medical...
mRNA vaccines: are they the way forward?
mRNA vaccine technology is broadening the scope of effective vaccine-based solutions that can mitigate the spread of harmful pathogens in infectious and non-infectious diseases.
For...
Defence advances to phase I clinical trials of the Accum technology
Defence Therapeutics Inc. is pleased to update its stakeholders on its completed achievements and outline the future milestones for AccumTM set for 2023.
Over the...
Defence Therapeutics begin toxicology study on intranasal AccutoxTM
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies is pleased to announce the start...
Defence Therapeutics has melanoma vaccine validated
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the validation...
New discovery could lead Epstein-Barr virus vaccines
Researchers from MedUni Vienna have found a specific immune response to the virus Epstein-Barr virus that could help the development of new vaccines.
The research...
Defence Therapeutics launch Accum-mRNA vaccine programme
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the advancement...
Defence Therapeutics are using Accum technology in mRNA vaccines
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is currently working on combining its...
Is it time TB vaccines were improved?
A new study commissioned by the World Health Organization (WHO) has predicted high health and economic returns from investment in new TB vaccines.
According to...
Towards the next Council conclusions: are we doing enough for adult immunisation?
Ahead of a meeting between EU health ministers on vaccination policy in November this year, Mariano Votta and Daniela Quaggia from the Active Citizenship...
WHO: First data released on the global vaccine market since COVID
The World Health Organization (WHO) has captured the effects of COVID-19 on global vaccine markets in a new report.
WHO’s Global Vaccine Market Report...
The teenage meningitis vaccine delivers herd immunity to all ages
Researchers from the University of Oxford have found that the UK’s MenACWY meningitis vaccine programme generates herd protection protecting all age groups.
In the new...
Enhancing treatment efficacy and antigen delivery with Accum
Defence Therapeutics outlines the potential of their innovative AccumTM technology to improve intracellular antigen delivery and ultimately enhance treatments for cancer and infectious diseases.
Defence...
Scientists discover a novel method to extend the shelf life of vaccines
New research illuminates the necessity of extending the shelf life of vaccines and finds a new approach to mitigate common vaccine problems.
It is reported...
Defence’s ACCUMTM variant “A1” converts mesenchymal stromal cells into potent antigen presenting cells
Defence Therapeutics has announced groundbreaking news about the development of a novel anti-cancer cellular vaccine using reprogrammed mesenchymal stromal cells.
Defence Therapeutics Inc., a Canadian...
New mRNA cancer vaccine eliminates tumours
A new mRNA-based cancer vaccine shows potential in eliminating tumours and preventing recurrence in mice.
Cancer vaccines are a controversial topic with plenty of research...
Study finds BCG tuberculosis vaccine offers immune boosting benefits
A study of the BCG tuberculosis vaccine discovers immune boosting benefits in infants over a year after vaccination.
Researchers from the Murdoch Children’s Research Institute (MCRI) and...
New RSV vaccine demonstrates excellent protection
A new RSV vaccine has been shown to provide robust protection against infection in a rodent study at Boston Children's Hospital.
The research was performed...
New COVID vaccine patch fights variants better than needles
A COVID vaccine patch could be more effective than the traditional needle vaccine at fighting COVID variants.
An emerging study by the University of Queensland...
